Journal Thoracic Oncology

Abstracts Journal of Thoracic Oncology • Volume 12 Issue S1 January 2017
POSTER SESSION 1 - P1.08: SURGERY
SURGERY FOR LOCALLY ADVANCED AND ADVANCED NSCLC –
MONDAY, DECEMBER 5, 2016
P1.08-061 CLINICAL EXPERIENCE OF RIB RESECTION FOR LUNG
CANCER WITH CHEST WALL INVASION USING A PNEUMATIC HIGH
SPEED POWER DRILL SYSTEM
Yuichiro Ueda, Tatsuo Nakagawa, Yasuaki Tomioka, Toshiya Toyazaki, Masashi
Gotoh
Thoracic Surgery, Tenri Hospital, Tenri/Japan
Background: Rib resection is sometimes required for chest wall tumors or
lung cancer with localized chest wall invasion.There are some reports on
thoracoscopic rib resection, which may be much less invasive and provide
an excellent surgical view of the target. We have used a pneumatic high
speed power drill system, commonly used as a dentist’s drill, in order to be
accomplished less invasive thoracoscopic rib resection. Methods: A pneumatic
high speed power drill (HiLAN® GA520R B Braun Aesculap, Tokyo, Japan) was
inserted in the thoracic cavity and the head of the drill, which has a diamond
burr, adequately attached to the rib surface. The rib was then sheared by
whittling until dislocated. Cut pieces of bone tissue were removed by suction
with saline dropping on the head of the drill. Soft tissue including the parietal
pleura, intercostal muscle and vessels were dissected using power devices or
an electrical scalpel after cutting the ribs.
study, we investigated the short and long-term outcomes of completion
pneumonectomy compared with primary pneumonectomy in our single
institution. Methods: Between January 1997 and December 2014, 243 patients
who underwent pneumonectomy in our institution were enrolled in this
study. Retrospectively, we investigated the postoperative complication,
short and long-term outcomes of the patients who underwent completion
pneumonectomy (CP) and primary pneumonectomy (PP). CP was defined
as pneumonectomy in patients with previous lung resection conducting
a hilar manipulation. Results: Thirty-three patients (14%) of 243 patients
underwent CP. CP was performed for 28 malignant tumors and 5 benign
diseases. Postoperative severe complication (CTCAE Grade3 or more) occurred
in 36% of CP group and 12% of PP group (p